A RETROSPECTIVE ANALYSIS OF SECOND-LINE CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)

被引：0
|
作者：
Bramati, A. [1 ]
Moretti, A. [1 ]
Garassino, M. C. [2 ]
Califano, R. [3 ]
Farina, G. [4 ]
Lo Dico, M. [5 ]
Cinquini, M. [6 ]
Michetti, G. N. [7 ]
Tiseo, M. [8 ]
Zucali, P. A. [9 ]
机构：
[1] AO Osped Fatebenefratelli Oftalmico, Milan, Italy
[2] Fatebenefratelli & Ophtalm Hosp, Milan, Italy
[3] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[4] Osped Fatebenefratelli Oftalmico, Milan, Italy
[5] Civil Hosp Livorno, Div Med Oncol, Livorno, Italy
[6] Mario Negri Inst Pharmacol Res, Milan, Italy
[7] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[8] Parma Hosp, Parma, Italy
[9] IRCCS, Ist Clin Humanitas, Dept Oncol, Rozzano, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [31] Analysis of Second Surgery for Recurrence in Malignant Pleural Mesothelioma (MPM) Patients (P)
    Cedres, S.
    Romero, L.
    Assaf, J. D.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Molina, G.
    Garcia-Illescas, D.
    Sanchez, L.
    Rosado, J.
    Carbonell, C.
    Frigola, J.
    Amat, R.
    Gonzalo, J.
    Navarro, V.
    Dienstmann, R.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S323 - S323
  • [32] RETROSPECTIVE REVIEW OF PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Cedres Perez, S. M.
    Torrejon, D.
    Martinez, P.
    Nunez, I.
    Mulet-Margalef, N.
    Rodriguez-Freixinos, V.
    Montero, M. A.
    Felip, E.
    LUNG CANCER, 2011, 71 : S48 - S48
  • [33] Treatment with gemcitabine and vinorelbine (GEMVIN) as second-line chemotherapy in pemetrexed-pretreated patients with malignant pleural mesotheliorna (MPM)
    Zucali, P. A.
    Garassino, I.
    Ceresoli, G. L.
    De Vincenzo, F.
    Cavina, R.
    Campagnoli, E.
    Salaminia, S.
    Soto-Parra, H. J.
    Santoro, A.
    LUNG CANCER, 2006, 54 : S48 - S49
  • [34] Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really “Raising the Bar?”
    Vincenzo Di Noia
    Emanuele Vita
    Miriam Ferrara
    Antonia Strippoli
    Michele Basso
    Giovanni Schinzari
    Alessandra Cassano
    Emilio Bria
    Carlo Barone
    Ettore D’Argento
    Current Treatment Options in Oncology, 2019, 20
  • [35] Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"
    Di Noia, Vincenzo
    Vita, Emanuele
    Ferrara, Miriam
    Strippoli, Antonia
    Basso, Michele
    Schinzari, Giovanni
    Cassano, Alessandra
    Bria, Emilio
    Barone, Carlo
    D'Argento, Ettore
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (03)
  • [36] Second-line treatment in malignant pleural mesothelioma: translating the evidence into clinical practice
    Ceresoli, Giovanni Luca
    LUNG CANCER MANAGEMENT, 2014, 3 (03) : 263 - 271
  • [37] Analysis of chemotherapy efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p).
    Perez, Susana Cedres
    Pastrana, Juan David Assaf
    Iranzo, Patricia
    Callejo, Ana
    Pardo, Nuria
    Navarro, Alejandro
    Martinez-Marti, Alex
    Castaneda, David Humberto Marmolejo
    Lostes, Julia
    Gonzalo, Javier
    Frigola, Joan
    Carbonell, Caterina
    Amat, Ramon
    Pedrola, Anna
    Dienstmann, Rodrigo
    Felip, Enriqueta
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] SECOND-LINE THERAPY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. FRENCH RETROSPECTIVE STUDY 2005-2006
    Margery, Jacques
    Ruffie, Pierre
    Le Floch, Herve
    Planchard, David
    Riviere, Frederic
    Gaspard, Wanda
    Saint Blancard, Patrick
    Besse, Benjamin
    Vaylet, Fabien
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1364 - S1365
  • [39] Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)
    Margery, J.
    Riviere, F.
    Planchard, D.
    Le Floch, H.
    Ferrand, F. -R.
    Mairovitz, A.
    Besse, B.
    Vaylet, F.
    Ruffie, P.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2010, 66 (04) : 255 - 259
  • [40] LACK OF RESPONSE TO CHEMOTHERAPY FOR PREVIOUSLY TREATED MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Zauderer, Marjorie G.
    Kass, Samantha L.
    Sima, Camelia S.
    Ginsberg, Michelle S.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S638 - S639
12345